Cargando…

Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease

Several postmortem studies have shown iron accumulation in the substantia nigra of Parkinson’s disease patients. Iron concentration can be estimated via MRI- [Formula: see text] mapping. To assess the changes in [Formula: see text] occurring in Parkinson’s disease patients compared to controls, a mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Khedher, Laila, Bonny, Jean-Marie, Marques, Ana, Durand, Elodie, Pereira, Bruno, Chupin, Marie, Vidal, Tiphaine, Chassain, Carine, Defebvre, Luc, Carriere, Nicolas, Fraix, Valerie, Moro, Elena, Thobois, Stéphane, Metereau, Elise, Mangone, Graziella, Vidailhet, Marie, Corvol, Jean-Christophe, Lehéricy, Stéphane, Menjot de Champfleur, Nicolas, Geny, Christian, Spampinato, Umberto, Meissner, Wassilios, Frismand, Solène, Schmitt, Emmanuelle, Doé de Maindreville, Anne, Portefaix, Christophe, Remy, Philippe, Fénelon, Gilles, Luc Houeto, Jean, Colin, Olivier, Rascol, Olivier, Peran, Patrice, Durif, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668635/
https://www.ncbi.nlm.nih.gov/pubmed/36279753
http://dx.doi.org/10.1016/j.nicl.2022.103231
_version_ 1784831957552594944
author Khedher, Laila
Bonny, Jean-Marie
Marques, Ana
Durand, Elodie
Pereira, Bruno
Chupin, Marie
Vidal, Tiphaine
Chassain, Carine
Defebvre, Luc
Carriere, Nicolas
Fraix, Valerie
Moro, Elena
Thobois, Stéphane
Metereau, Elise
Mangone, Graziella
Vidailhet, Marie
Corvol, Jean-Christophe
Lehéricy, Stéphane
Menjot de Champfleur, Nicolas
Geny, Christian
Spampinato, Umberto
Meissner, Wassilios
Frismand, Solène
Schmitt, Emmanuelle
Doé de Maindreville, Anne
Portefaix, Christophe
Remy, Philippe
Fénelon, Gilles
Luc Houeto, Jean
Colin, Olivier
Rascol, Olivier
Peran, Patrice
Durif, Franck
author_facet Khedher, Laila
Bonny, Jean-Marie
Marques, Ana
Durand, Elodie
Pereira, Bruno
Chupin, Marie
Vidal, Tiphaine
Chassain, Carine
Defebvre, Luc
Carriere, Nicolas
Fraix, Valerie
Moro, Elena
Thobois, Stéphane
Metereau, Elise
Mangone, Graziella
Vidailhet, Marie
Corvol, Jean-Christophe
Lehéricy, Stéphane
Menjot de Champfleur, Nicolas
Geny, Christian
Spampinato, Umberto
Meissner, Wassilios
Frismand, Solène
Schmitt, Emmanuelle
Doé de Maindreville, Anne
Portefaix, Christophe
Remy, Philippe
Fénelon, Gilles
Luc Houeto, Jean
Colin, Olivier
Rascol, Olivier
Peran, Patrice
Durif, Franck
author_sort Khedher, Laila
collection PubMed
description Several postmortem studies have shown iron accumulation in the substantia nigra of Parkinson’s disease patients. Iron concentration can be estimated via MRI- [Formula: see text] mapping. To assess the changes in [Formula: see text] occurring in Parkinson’s disease patients compared to controls, a multicentre transversal study was carried out on a large cohort of Parkinson’s disease patients (n = 163) with matched controls (n = 82). In this study, 44 patients and 11 controls were removed due to motion artefacts, 21 patient and 6 controls to preserve matching. Thus, 98 patients and 65 age and sex-matched healthy subjects were selected with enough image quality. The study was conducted on patients with early to late stage Parkinson's disease. The images were acquired at 3Tesla in 12 clinical centres. [Formula: see text] values were measured in subcortical regions of interest (substantia nigra, red nucleus, striatum, globus pallidus externus and globus pallidus internus) contralateral (dominant side) and ipsilateral (non dominant side) to the most clinically affected hemibody. As the observed inter-subject [Formula: see text] variability was significantly higher than the disease effect, an original strategy (intrasubject subcortical quantitative referencing, ISQR) was developed using the measurement of [Formula: see text] in the red nucleus as an intra-subject reference. [Formula: see text] values significantly increased in Parkinson’s disease patients when compared with controls; in the substantia nigra (SN) in the dominant side (D) and in the non dominant side (ND), respectively (P(SN_D) and P(SN_ND) < 0.0001). After stratification into four subgroups according to the disease duration, no significant [Formula: see text] difference was found in all regions of interest when comparing Parkinson’s disease subgroups. By applying our ISQR strategy, [Formula: see text] values significantly increased in the substantia nigra (P(SN_D) and P(SN_ND) < 0.0001) when comparing all Parkinson’s disease patients to controls. [Formula: see text] values in the substantia nigra significantly increased with the disease duration (P(SN_D) = 0.01; P(SN_ND) = 0.03) as well as the severity of the disease (Hoehn & Yahr scale <2 and ≥ 2, P(SN_D) = 0.02). Additionally, correlations between [Formula: see text] and clinical features, mainly related to the severity of the disease, were found. Our results support the use of ISQR to reduce variations not directly related to Parkinson’s disease, supporting the concept that ISQR strategy is useful for the evaluation of Parkinson’s disease.
format Online
Article
Text
id pubmed-9668635
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96686352022-11-18 Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease Khedher, Laila Bonny, Jean-Marie Marques, Ana Durand, Elodie Pereira, Bruno Chupin, Marie Vidal, Tiphaine Chassain, Carine Defebvre, Luc Carriere, Nicolas Fraix, Valerie Moro, Elena Thobois, Stéphane Metereau, Elise Mangone, Graziella Vidailhet, Marie Corvol, Jean-Christophe Lehéricy, Stéphane Menjot de Champfleur, Nicolas Geny, Christian Spampinato, Umberto Meissner, Wassilios Frismand, Solène Schmitt, Emmanuelle Doé de Maindreville, Anne Portefaix, Christophe Remy, Philippe Fénelon, Gilles Luc Houeto, Jean Colin, Olivier Rascol, Olivier Peran, Patrice Durif, Franck Neuroimage Clin Regular Article Several postmortem studies have shown iron accumulation in the substantia nigra of Parkinson’s disease patients. Iron concentration can be estimated via MRI- [Formula: see text] mapping. To assess the changes in [Formula: see text] occurring in Parkinson’s disease patients compared to controls, a multicentre transversal study was carried out on a large cohort of Parkinson’s disease patients (n = 163) with matched controls (n = 82). In this study, 44 patients and 11 controls were removed due to motion artefacts, 21 patient and 6 controls to preserve matching. Thus, 98 patients and 65 age and sex-matched healthy subjects were selected with enough image quality. The study was conducted on patients with early to late stage Parkinson's disease. The images were acquired at 3Tesla in 12 clinical centres. [Formula: see text] values were measured in subcortical regions of interest (substantia nigra, red nucleus, striatum, globus pallidus externus and globus pallidus internus) contralateral (dominant side) and ipsilateral (non dominant side) to the most clinically affected hemibody. As the observed inter-subject [Formula: see text] variability was significantly higher than the disease effect, an original strategy (intrasubject subcortical quantitative referencing, ISQR) was developed using the measurement of [Formula: see text] in the red nucleus as an intra-subject reference. [Formula: see text] values significantly increased in Parkinson’s disease patients when compared with controls; in the substantia nigra (SN) in the dominant side (D) and in the non dominant side (ND), respectively (P(SN_D) and P(SN_ND) < 0.0001). After stratification into four subgroups according to the disease duration, no significant [Formula: see text] difference was found in all regions of interest when comparing Parkinson’s disease subgroups. By applying our ISQR strategy, [Formula: see text] values significantly increased in the substantia nigra (P(SN_D) and P(SN_ND) < 0.0001) when comparing all Parkinson’s disease patients to controls. [Formula: see text] values in the substantia nigra significantly increased with the disease duration (P(SN_D) = 0.01; P(SN_ND) = 0.03) as well as the severity of the disease (Hoehn & Yahr scale <2 and ≥ 2, P(SN_D) = 0.02). Additionally, correlations between [Formula: see text] and clinical features, mainly related to the severity of the disease, were found. Our results support the use of ISQR to reduce variations not directly related to Parkinson’s disease, supporting the concept that ISQR strategy is useful for the evaluation of Parkinson’s disease. Elsevier 2022-10-12 /pmc/articles/PMC9668635/ /pubmed/36279753 http://dx.doi.org/10.1016/j.nicl.2022.103231 Text en © 2022 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Khedher, Laila
Bonny, Jean-Marie
Marques, Ana
Durand, Elodie
Pereira, Bruno
Chupin, Marie
Vidal, Tiphaine
Chassain, Carine
Defebvre, Luc
Carriere, Nicolas
Fraix, Valerie
Moro, Elena
Thobois, Stéphane
Metereau, Elise
Mangone, Graziella
Vidailhet, Marie
Corvol, Jean-Christophe
Lehéricy, Stéphane
Menjot de Champfleur, Nicolas
Geny, Christian
Spampinato, Umberto
Meissner, Wassilios
Frismand, Solène
Schmitt, Emmanuelle
Doé de Maindreville, Anne
Portefaix, Christophe
Remy, Philippe
Fénelon, Gilles
Luc Houeto, Jean
Colin, Olivier
Rascol, Olivier
Peran, Patrice
Durif, Franck
Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease
title Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease
title_full Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease
title_fullStr Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease
title_full_unstemmed Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease
title_short Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease
title_sort intrasubject subcortical quantitative referencing to boost mri sensitivity to parkinson's disease
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668635/
https://www.ncbi.nlm.nih.gov/pubmed/36279753
http://dx.doi.org/10.1016/j.nicl.2022.103231
work_keys_str_mv AT khedherlaila intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT bonnyjeanmarie intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT marquesana intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT durandelodie intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT pereirabruno intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT chupinmarie intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT vidaltiphaine intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT chassaincarine intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT defebvreluc intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT carrierenicolas intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT fraixvalerie intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT moroelena intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT thoboisstephane intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT metereauelise intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT mangonegraziella intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT vidailhetmarie intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT corvoljeanchristophe intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT lehericystephane intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT menjotdechampfleurnicolas intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT genychristian intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT spampinatoumberto intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT meissnerwassilios intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT frismandsolene intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT schmittemmanuelle intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT doedemaindrevilleanne intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT portefaixchristophe intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT remyphilippe intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT fenelongilles intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT luchouetojean intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT colinolivier intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT rascololivier intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT peranpatrice intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT duriffranck intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease
AT intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease